CBD Market Outlook / FDA Approval Expected Soon The CBD market is expected to have a CAGR of 21.2% until 2028. The increased demand due to its healing properties, uses for stress and sleep, rising public approval, and government approval are estimated to be the leading industry drivers.
https://www.grandviewresearch.com/industry-analysis/cannabidiol-cbd-market
HempFusion is a company capitalizing on this industry growth, though, not fully dependent on CBD products due to their highly diversified portfolio of products. Additionally, HempFusion has a wide international retail/online distribution network with products in stores such as Whole Foods, Publix, Amazon, and many more.
Many believe that 2022 will be the year that we see FDA approval for hemp extracts, and with $CBD having a focus on compliance, they'll begin to pick up traction in the space. The current market cap of $16M makes the company very undervalued when considering past valuations and future outlook in the industry. Definitely worth a look.